This condition, known as leaky gut, allows yeast, toxins, and undigested particles to escape into the bloodstream, triggering immune reactions and systemic inflammation
*Correspondence: Zheer Kejlberg Al-Mashhadi, [email protected] This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Severe GI adverse reactions Severe GI adverse reactions have been reported in patients receiving Wegovy
With respect to non-glycaemic outcomes, GLP1-RAs promote weight loss and have been investigated in randomised placebo-controlled trials focusing on cardiovascular outcomes in adults with type 2 diabetes and high cardiovascular risk
By disrupting the interaction between FOXO4 and p53, FOXO4-DRI induces apoptosis (programmed cell death) in senescent cells, reducing their harmful effects
